These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2546850

  • 1. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M.
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 6. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A.
    Lancet; 1988 Dec 17; 2(8625):1392-4. PubMed ID: 2904525
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R, Gyr K.
    Eur J Anaesthesiol Suppl; 1988 Dec 17; 2():139-46. PubMed ID: 2842130
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of acute hepatic encephalopathy with flumazenil].
    Viel E, de La Coussaye JE, Bassoul B, Saissi G, Eledjam JJ.
    Ann Fr Anesth Reanim; 1990 Dec 17; 9(4):386-9. PubMed ID: 2119157
    [Abstract] [Full Text] [Related]

  • 9. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D, Tahiri C, Lanchier C, Navelet Y, Durand P, Rousset A.
    Intensive Care Med; 1995 Mar 17; 21(3):253-6. PubMed ID: 7790615
    [Abstract] [Full Text] [Related]

  • 10. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA, Basile AS, Yurdaydin C, Skolnich P.
    Adv Exp Med Biol; 1993 Mar 17; 341():57-69. PubMed ID: 8116487
    [Abstract] [Full Text] [Related]

  • 11. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Mar 17; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 Mar 17; (2):CD002798. PubMed ID: 15106178
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
    Dursun M, Caliskan M, Canoruc F, Aluclu U, Canoruc N, Tuzcu A, Yilmaz S, Isikdogan A, Ertem M.
    Swiss Med Wkly; 2003 Feb 22; 133(7-8):118-23. PubMed ID: 12644958
    [Abstract] [Full Text] [Related]

  • 14. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ, Bansky G.
    Schweiz Med Wochenschr; 1990 Apr 14; 120(15):553-6. PubMed ID: 2159659
    [Abstract] [Full Text] [Related]

  • 15. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
    van der Rijt CC, de Knegt RJ, Schalm SW, Terpstra OT, Mechelse K.
    Metab Brain Dis; 1990 Sep 14; 5(3):131-41. PubMed ID: 2273999
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug 14; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 18. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Aug 14; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 19. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Meyer HP, Legemate DA, van den Brom W, Rothuizen J.
    Metab Brain Dis; 1998 Sep 14; 13(3):241-51. PubMed ID: 9804368
    [Abstract] [Full Text] [Related]

  • 20. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD, Olasmaa M.
    Neurochem Res; 1990 Feb 14; 15(2):193-7. PubMed ID: 2159124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.